Home › Multiple Myeloma › Michigan › Lansing
Multiple Myeloma clinical trials in Lansing, MI
4 studies for Multiple Myeloma are looking for participants at sites in and around Lansing (within about 30 miles). Open a study to see who can join and how to contact the study team.
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
RecruitingPhase 2
- University of Michigan Health - Sparrow Lansing, Lansing
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
RecruitingPhase 3
- University of Michigan Health - Sparrow Lansing, Lansing
Iberdomide and Daratumumab as Maintenance Therapy After an Autologous Stem Cell Transplant for Multiple Myeloma
RecruitingPhase 2
- KCI at McLaren Greater Lansing, Lansing
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
RecruitingPhase 3
- University of Michigan Health - Sparrow Lansing, Lansing
About Multiple Myeloma
Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. Discover symptoms, diagnostic tests, and treatments for myeloma.
More about Multiple Myeloma on MedlinePlus
Multiple Myeloma trials in other cities
- New York City, NY60 studies
- Boston, MA42 studies
- Atlanta, GA41 studies
- Houston, TX38 studies
- Durham, NC37 studies
- Nashville, TN32 studies
- Denver, CO26 studies
- Columbus, OH24 studies
- Baldwin Park, CA23 studies
- St. Louis, MO23 studies
- Rochester, MN23 studies
- Washington, DC22 studies
Other studies in Lansing
- Lung Cancer11 studies
- Prostate Cancer10 studies
- Breast Cancer10 studies
- Non-Small Cell Lung Cancer9 studies
- Cancer (all types)7 studies
- Bladder Cancer5 studies
- Laryngeal Cancer5 studies
- Disorders of Excessive Somnolence5 studies
- Urothelial (Transitional Cell) Carcinoma4 studies
- Kidney Cancer (Renal Cell Carcinoma)4 studies
- Endometrial Cancer4 studies
- Head and Neck Squamous Cell Carcinoma4 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.